Illumina (0J8Z) Share Forecast & Price Target

Compare

0 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

0J8Z Analyst Ratings

Hold

5 Buy

6 Hold

3 Sell

Based on 14 analysts giving stock ratings to

Illumina

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

0J8Z Stock 12 Month Forecast

Average Price Target

$115.36

▼(-4.28% Downside)

Based on 14 Wall Street analysts offering 12 month price targets for Illumina in the last 3 months. The average price target is $115.36 with a high forecast of $185.00 and a low forecast of $80.00. The average price target represents a -4.28% change from the last price of $120.52.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"75":"$75","186":"$186","102.75":"$102.8","130.5":"$130.5","158.25":"$158.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":185,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$185.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":115.36,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$115.36</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":80,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$80.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[75,102.75,130.5,158.25,186],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,100.785,107.26307692307692,113.74115384615385,120.21923076923076,126.69730769230769,133.17538461538462,139.65346153846153,146.13153846153847,152.60961538461538,159.0876923076923,165.56576923076923,172.04384615384615,178.5219230769231,{"y":185,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,100.785,101.90615384615384,103.02730769230769,104.14846153846153,105.26961538461538,106.39076923076922,107.51192307692307,108.63307692307693,109.75423076923077,110.87538461538462,111.99653846153846,113.11769230769231,114.23884615384615,{"y":115.36,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,100.785,99.18615384615384,97.58730769230769,95.98846153846154,94.38961538461538,92.79076923076923,91.19192307692308,89.59307692307692,87.99423076923077,86.39538461538461,84.79653846153846,83.19769230769231,81.59884615384615,{"y":80,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":127.35,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":148.88,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":144.159,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":133.589,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 30, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":133.01,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":88.784,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 30, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 9</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.04,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.85,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.27,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":98.27,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":95.333,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":99.773,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":100.785,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$185.00

Average Price Target$115.36

Lowest Price Target$80.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Michael Ryskin

Bank of America Securities

$80

Sell

-33.62%

Downside

Reiterated

11/06/25

Bank of America Securities Keeps Their Sell Rating on Illumina (ILMN)

Kyle Mikson CFA

Canaccord Genuity

$112

Hold

-7.07%

Downside

Reiterated

11/06/25

Illumina (ILMN) Gets a Hold from Canaccord Genuity

Daniel Arias

Stifel Nicolaus

$135

Buy

12.01%

Upside

Reiterated

11/06/25

Illumina (ILMN) Receives a Buy from Stifel Nicolaus

Cira Diagnissa

TR | OpenAI - 4o

$107→$138

Buy

14.50%

Upside

Reiterated

11/01/25

AI Generated ArticleAI Generated Article

Daniel Brennan

TD Cowen

$110→$115

Hold

-4.58%

Downside

Reiterated

10/31/25

Illumina's Hold Rating: Balancing Growth Potential with Competitive and Financial Challenges

Dan Leonard

UBS

$110→$120

Hold

-0.43%

Downside

Reiterated

10/31/25

Analysts Offer Insights on Healthcare Companies: Guardant Health (NASDAQ: GH), Baxter International (NYSE: BAX) and Illumina (NASDAQ: ILMN)

Catherine Ramsey Schulte

Robert W. Baird

$105→$109

Hold

-9.56%

Downside

Reiterated

10/31/25

Illumina price target raised to $109 from $105 at BairdIllumina price target raised to $109 from $105 at Baird

David Westenberg

Piper Sandler

$185

Buy

53.50%

Upside

Reiterated

10/31/25

Illumina (ILMN) Receives a Buy from Piper Sandler

Vijay Kumar

Evercore ISI

$132→$142

Buy

17.82%

Upside

Reiterated

10/31/25

Illumina price target raised to $142 from $132 at Evercore ISIIllumina price target raised to $142 from $132 at Evercore ISI

Casey Woodring

J.P. Morgan

$100→$105

Hold

-12.88%

Downside

Reiterated

10/31/25

Illumina price target raised to $105 from $100 at JPMorganIllumina price target raised to $105 from $100 at JPMorgan

Luke Sergott

Barclays

$95→$100

Sell

-17.03%

Downside

Reiterated

10/31/25

Patrick B Donnelly

Citi

$80

Sell

-33.62%

Downside

Reiterated

10/15/25

We assign ILMN a Sell rating. Our $80 target price applies a 50/50 split between a 12.5x EV/EBITDA multiple on our Q5-Q8 EBITDA estimate and a 14.5x P/E multiple on our Q5-Q8 EPS estimate.

Subbu Nambi

Guggenheim

$114

Buy

-5.41%

Downside

Reiterated

09/26/25

Illumina (ILMN) Gets a Buy from Guggenheim

Conor McNamara

RBC Capital

$126→$124

Buy

2.89%

Upside

Reiterated

09/02/25

Illumina (ILMN) Receives a Buy from RBC Capital

Narumi Nakagiri

Daiwa

$94

Hold

-22.00%

Downside

Downgraded

08/12/25

Illumina downgraded to Neutral from Outperform at DaiwaIllumina downgraded to Neutral from Outperform at Daiwa

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Michael Ryskin

Bank of America Securities

$80

Sell

-33.62%

Downside

Reiterated

11/06/25

Bank of America Securities Keeps Their Sell Rating on Illumina (ILMN)

Kyle Mikson CFA

Canaccord Genuity

$112

Hold

-7.07%

Downside

Reiterated

11/06/25

Illumina (ILMN) Gets a Hold from Canaccord Genuity

Daniel Arias

Stifel Nicolaus

$135

Buy

12.01%

Upside

Reiterated

11/06/25

Illumina (ILMN) Receives a Buy from Stifel Nicolaus

Cira Diagnissa

TR | OpenAI - 4o

$107→$138

Buy

14.50%

Upside

Reiterated

11/01/25

AI Generated ArticleAI Generated Article

Daniel Brennan

TD Cowen

$110→$115

Hold

-4.58%

Downside

Reiterated

10/31/25

Illumina's Hold Rating: Balancing Growth Potential with Competitive and Financial Challenges

Dan Leonard

UBS

$110→$120

Hold

-0.43%

Downside

Reiterated

10/31/25

Analysts Offer Insights on Healthcare Companies: Guardant Health (NASDAQ: GH), Baxter International (NYSE: BAX) and Illumina (NASDAQ: ILMN)

Catherine Ramsey Schulte

Robert W. Baird

$105→$109

Hold

-9.56%

Downside

Reiterated

10/31/25

Illumina price target raised to $109 from $105 at BairdIllumina price target raised to $109 from $105 at Baird

David Westenberg

Piper Sandler

$185

Buy

53.50%

Upside

Reiterated

10/31/25

Illumina (ILMN) Receives a Buy from Piper Sandler

Vijay Kumar

Evercore ISI

$132→$142

Buy

17.82%

Upside

Reiterated

10/31/25

Illumina price target raised to $142 from $132 at Evercore ISIIllumina price target raised to $142 from $132 at Evercore ISI

Casey Woodring

J.P. Morgan

$100→$105

Hold

-12.88%

Downside

Reiterated

10/31/25

Illumina price target raised to $105 from $100 at JPMorganIllumina price target raised to $105 from $100 at JPMorgan

Luke Sergott

Barclays

$95→$100

Sell

-17.03%

Downside

Reiterated

10/31/25

Patrick B Donnelly

Citi

$80

Sell

-33.62%

Downside

Reiterated

10/15/25

We assign ILMN a Sell rating. Our $80 target price applies a 50/50 split between a 12.5x EV/EBITDA multiple on our Q5-Q8 EBITDA estimate and a 14.5x P/E multiple on our Q5-Q8 EPS estimate.

Subbu Nambi

Guggenheim

$114

Buy

-5.41%

Downside

Reiterated

09/26/25

Illumina (ILMN) Gets a Buy from Guggenheim

Conor McNamara

RBC Capital

$126→$124

Buy

2.89%

Upside

Reiterated

09/02/25

Illumina (ILMN) Receives a Buy from RBC Capital

Narumi Nakagiri

Daiwa

$94

Hold

-22.00%

Downside

Downgraded

08/12/25

Illumina downgraded to Neutral from Outperform at DaiwaIllumina downgraded to Neutral from Outperform at Daiwa

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Illumina

1 Month

xxx

Success Rate

16/29 ratings generated profit

Average Return

-0.54%

reiterated a xxx

rating 2 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 55.17% of your transactions generating a profit, with an average return of -0.54% per trade.

3 Months

xxx

Success Rate

17/32 ratings generated profit

Average Return

+2.33%

reiterated a xxx

rating 8 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 53.13% of your transactions generating a profit, with an average return of +2.33% per trade.

1 Year

Doug SchenkelWolfe Research

Success Rate

25/32 ratings generated profit

Average Return

+16.54%

reiterated a buy rating 8 months ago

Copying Doug Schenkel's trades and holding each position for 1 Year would result in 78.13% of your transactions generating a profit, with an average return of +16.54% per trade.

2 Years

xxx

Success Rate

21/32 ratings generated profit

Average Return

+36.10%

reiterated a xxx

rating 8 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 65.63% of your transactions generating a profit, with an average return of +36.10% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0J8Z Analyst Recommendation Trends

Rating

Jun 25

Jul 25

Aug 25

Sep 25

Oct 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 0J8Z has received 12 Buy Ratings, 27 Hold Ratings, and 10 Sell Ratings. 0J8Z average Analyst price target in the past 3 months is 115.36.

Each month's total comprises the sum of three months' worth of ratings.

0J8Z Financial Forecast

0J8Z Earnings Forecast

Next quarter’s earnings estimate for 0J8Z is $1.20 with a range of $0.96 to $1.30. The previous quarter’s EPS was $1.34. 0J8Z beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year 0J8Z has Preformed in-line its overall industry.

0J8Z Sales Forecast

Next quarter’s sales forecast for 0J8Z is $1.10B with a range of $1.08B to $1.12B. The previous quarter’s sales results were $1.08B. 0J8Z beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year 0J8Z has Preformed in-line its overall industry.

0J8Z Stock Forecast FAQ

What is GB:0J8Z’s average 12-month price target, according to analysts?

Based on analyst ratings, Illumina’s 12-month average price target is 115.36.

What is GB:0J8Z’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for GB:0J8Z, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Illumina a Buy, Sell or Hold?

Illumina has a consensus rating of Hold, which is based on 5 buy ratings, 6 hold ratings and 3 sell ratings.

What is Illumina’s share price target?

The average share price target for Illumina is 115.36. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $185.00 ,and the lowest forecast is $80.00. The average share price target represents -4.28% Decrease from the current price of $120.52.

What do analysts say about Illumina?

Illumina’s analyst rating consensus is a Hold. This is based on the ratings of 14 Wall Streets Analysts.

How can I buy shares of Illumina?

To buy shares of GB:0J8Z, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Illumina (0J8Z) Share Forecast & Price Target

0J8Z Analyst Ratings

0J8Z Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Illumina

0J8Z Analyst Recommendation Trends

0J8Z Financial Forecast

0J8Z Earnings Forecast

0J8Z Sales Forecast

0J8Z Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts